Completed × Observational × Chemotherapy, Adjuvant × Clear all TOX-FRAIL
Completed
72 enrolled
CD155 in Bladder Cancer
Completed
151 enrolled
POROMS
Completed
30,000 enrolled
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Completed
88 enrolled
Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy
Completed
10,328 enrolled
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Completed
1,000 enrolled
Chemotherapy for Resectable Colorectal Liver Metastases
Completed
967 enrolled
Predictors of Recurrence for High Risk Endometrial Cancer Patients
Completed
92 enrolled
Factors Predicting Recurrence in Rectal Cancer After Surgery
Completed
188 enrolled
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Completed
1,111 enrolled
Head & Neck Cancer Survivorship: Physical and Functional Status
Completed
23 enrolled
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Completed
20 enrolled
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Completed
35 enrolled